In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

New - ESC Guidance for the Diagnosis and Management of Heart Disease during COVID-19


Leading experts treating COVID-19 patients provide advice on managing cardiovascular disease during the pandemic. The European Society of Cardiology (ESC) guidance is published online.1

The novel coronavirus not only causes viral pneumonia but also has major implications for the cardiovascular system.

Heart and stroke patients are more likely to have severe cases of COVID-19, as are people with other risk factors, including advanced age, diabetes, hypertension and obesity.

In addition, COVID-19 patients may develop heart damage, which raises their chance of dying.

This detailed document provides healthcare professionals the best available knowledge, based on practical experience, on how to diagnose and manage cardiovascular conditions in COVID-19 patients, treat the coronavirus infection, and organise and prioritise care. It will be updated as more evidence is gathered.




Notes to editor

Authors: ESC Press Office
Tel: +33 (0)4 89 87 20 85

Mobile: +33 (0)7 8531 2036

Follow us on Twitter @ESCardioNews 



12020 ESC Guidance for the Diagnosis and Management of CV Disease in the Context of the COVID-19 Pandemic


For the latest science on COVID-19 and heart disease visit the ESC’s dedicated web page: COVID-19 and Cardiology.


Follow us on Twitter @ESCardioNews to hear when new material is published.


See COVID-19 and Heart Patients Q&A here.


About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.